OMDA
Omada Health, Inc.
$23.28
-0.27 (-1.15%)
At close · Jul 10
Market Cap
$1.37B
Shares
59,448,507
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$23.28
Open$23.56
Day$22.72–23.75
52W$10.28–26.92
Avg vol 30d1.1M
Short int7.8M · 13.1% float · 6.5d
Short vol22%
Last earningsMay 7, 2026
DataJun 2025–Jul 2026
Filing10-Q · May 8
Up next
Next earnings call
Aug 6, 2026
Est · unconfirmed
· in 4 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 8, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Very Bullish
Fundamentals
Excellent
Quant / Vol
Very High
Market backdrop
VIX 15 · calm
Equity put/call 0.55
Technical
price trend
50 / 200-day cross
Golden cross
Price vs 200-day avg
+36%
above
Price vs 50-day avg
+30%
above
RSI (14)
78
overbought
MACD trend
Positive
52-week position
78%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+27%
trailing
6-month return
+50%
trailing
YTD return
+48%
this year
Relative strength
+41%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
Golden cross
50d $18 › 200d $17 — 50d above 200d
Institutional flow
Accumulating
4 of 139 funds reported for Jun 30 · net +2.1K sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
13.11% of float · ▼ -0.0% MoM · 6.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
139 holders — near 1-yr high, broad support
Squeeze score
68
elevated · 0–100
Fundamentals
Revenue growth
+53%
Y/Y
Gross margin
66%
expanding
EPS growth
+94%
Y/Y
Free cash flow
$16.9M
Valuation
P/E 30.8
below peers
Balance sheet
$222.0M
net cash
Quant / Vol
risk profile
Volatility
58%
annualized · 1-yr
Max drawdown
−59%
past year
ATR
4.3%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed May 7, 2026
Revenue
· year ending December 31, 2026
Initiated
$322M – $330M
prior FY $260.21M
midpoint +25.3% Y/Y
Adjusted EBITDA
· year ending December 31, 2026
Initiated
$14M – $20M
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
Golden cross
Bullish
Price vs 200-day avg
+36%
Bullish
Price vs 50-day avg
+30%
Bullish
RSI (14)
78
Bearish
MACD trend
Positive
Bullish
52-week position
78%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 4 of 6
Trend (MA cross)
Golden cross
50d $18 › 200d $17 — 50d above 200d
Institutional flow
Accumulating
4 of 139 funds reported for Jun 30 · net +2.1K sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
13.11% of float · ▼ -0.0% MoM · 6.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
139 holders — near 1-yr high, broad support
Price context
position in its 52-week range
52-wk low $10
Now $23 · 78%
52-wk high $27
vs 200-day avg +36%
vs 50-day avg +30%
50-day above 200-day golden cross
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | $1M | first quarter | — |
|
|
|||
| Gross margin | 62% | first quarter | — |
| Non-GAAP gross margin non-GAAP | 64% | first quarter | — |
|
|
|||
| net new members | 139,000 | Q1 2026 call | — |
| Total members | 886,000 | year end | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Health Information Services — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
OMDA
this stock
Omada Health, Inc.
|
$1.37B | +47.5% | +53.2% | 30.8 | 13.1% |
|
VEEV
Veeva Systems Inc
|
$30.88B | -14.8% | +28.1% | 33.7 | 4.6% |
|
PMDIY
Pro Medicus Ltd./ADR
|
$15.67B | -9.4% | — | — | 0.0% |
|
BTSG
BrightSpring Health Services, Inc.
|
$13.85B | +90.7% | -0.4% | 51.0 | 6.6% |
|
TEM
Tempus AI, Inc.
|
$11.16B | -1.4% | +65.8% | — | 18.7% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| OMDA | +4.0% | +27.1% | +50.2% | +6.1% | +47.5% |
| SPY | +0.8% | +2.0% | +8.9% | +0.7% | +10.2% |
| vs SPY | +3.2% | +25.1% | +41.3% | +5.4% | +37.3% |